The Family Firm’s CME Group CME Stock Holding History

The Family Firm’s Portfolio CME Stock Details CME Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-468	Closed	-$92K	–	320
2024 Q2	$92K	Buy	+468	New	+$96.7K	0.02%	290

Other funds holding CME

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

The Family Firm's CME Position: Q3 2024 in Review

The Family Firm sold out of CME Group (CME) in Q3 2024, closing a stake of 468 shares — an estimated $92K sold.

The Family Firm first reported a position in CME in Q2 2024 and held it in 1 quarter. The position peaked at $92K in Q2 2024. 1,390 funds tracked by Wall St. Rank hold CME as of Q3 2024.

The Family Firm reported no remaining CME Group position as of Q3 2024 after selling out during the quarter.
The Family Firm sold 468 CME Group shares in Q3 2024, an estimated $92K.
The Family Firm first reported a position in CME Group in Q2 2024 and held it in 1 quarter.
The Family Firm's CME Group position peaked at $92K in Q2 2024.
1,390 funds tracked by Wall St. Rank held CME Group as of Q3 2024.

Based on The Family Firm's 13F filing for Q3 2024, filed 17 Oct 2024.